2.17k followers • 15 symbols Watchlist by Yahoo Finance
This basket consists of stocks that serve the 18+ crowd, such as casinos, alcohol, tobacco, and strip clubs.
It wasn’t so long ago that publicly traded companies shied away from investing in the nascent marijuana industry, even as California and Colorado began the legalization trend. James Boyd, education coach at TD Ameritrade, pointed out some Canadian publicly traded cannabis-related companies now have dual listings on the New York Stock Exchange™ and Nasdaq™. The big news stories around the industry center on consuming companies, such as the 2018 news that beer and spirits maker Constellation Brands Inc (NYSE: STZ) increased its investment in Canadian medical-cannabis producer Canopy Growth Corp (NYSE: CGC) to 38%.
Altria has tried to offset this, with price increases on nearly all its brands and investments in vaping startup Juul Labs, pouch product on!, and cannabis company Cronos Group (CRON). On Friday, Morgan Stanley analyst Pamela Kaufman raised her rating on Altria to Equal Weight from Underweight, with a $44 price target. Altria was up 0.5% to $46.82 in morning trading on Friday.
The cigarette business isn’t exactly smoking these days. And as investors have moved away from Big Tobacco, lowering share prices, one of the biggest cigarette companies has also broadened its product ...
Las Vegas Sands (LVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Anheuser-Busch hasn't made a qualifying offer for the remaining shares of Craft Brew Alliance Inc. and will instead make an incentive payment of $20 million, Craft Brew said Friday. The action comes as the deadline for a qualifying offer, as indicated by the 2016 International Distribution Agreement, expires. Craft Brew's portfolio of brands includes Red Hook Brewery, Kona Brewing Co. and Square Mile Cider Co. "While disappointing, with this decision made, management can turn its attention to refining strategic alternatives to maximize shareholder value," said Craft Brew Chief Executive Andy Thomas in a statement. Creft Brew will host a call on September 5 to discuss its go-forward strategy. Craft Brew stock slipped 4.3% in Friday premarket trading, and is down nearly 33% over the past year. Anheuser-Busch InBev S.A. edged up 0.4% in premarket but has fallen 2.3% over the last 12 months. And the S&P 500 index has gained 2.3% for the past year.
(Bloomberg Opinion) -- Big food is salivating over fake meat after the blockbuster initial public offering of Beyond Meat Inc., the leading plant-based protein brand, in May. Traditional producers have rushed into the booming market for meat substitutes, which threaten to take a slice of their business. Tyson Foods Inc. was an early investor in Beyond Meat, but sold its stake before the company’s trading debut and announced its own line of faux meat. Other U.S. companies, such as Smithfield Foods Inc., are introducing alternative protein products. European giants are getting in on the act too, with Nestle SA snapping up California-based Sweet Earth two years ago and Unilever NV buying The Vegetarian Butcher last year.It’s a familiar playbook. The big drinks companies have bought craft brewers. Major cosmetics houses are blending more artisan scents into perfumes. But there’s one segment where the similarities – and potential pitfalls -- are striking: tobacco, which is trying to woo smokers with the products they describe as lower risk, such as electronic cigarettes. Just as the tobacco industry has turned to vaping products to cope with high taxes and declining rates of smoking, big food sees a growing market for meat substitutes as people eat less animal protein and governments slap taxes on their other unhealthy products (and even consider levies on red meat). But traditional food manufacturers eager for vegan profits may struggle with some of the same obstacles tobacco has faced with vaping: adoption and regulation.Just look at Japan. It’s the most developed nation for devices that heat, rather than burn, tobacco, accounting for about 25% of the market. While tech-savvy early adopters were quick to switch to the new devices, older generations were slower to follow suit.Meat substitutes could see a similar trajectory. Analysts at Barclays Plc point out that men drive demand for meat. Convincing them –particularly older generations to switch -- will be crucial. Plant protein substitutes also tend to be more expensive. The premium will need to be whittled away for consumption to be widespread.While there’s no suggestion that fake meat products cause harm in any way – as has been alleged in some cases with vaping – not everyone agrees that they are healthier than animal protein. Chipotle Mexican Grill Inc. said it would not be stocking meat alternatives because they are too processed for the burrito chain. Beyond Meat has hit back at the claims, saying that its products and facilities are more transparent than those in the meat industry. More importantly, faux meat manufacturers will need to keep innovating – and investing – to grow, just as tobacco companies have had to come up with ways to make electronic cigarettes more satisfying for smokers to encourage them to switch. Plant-based protein producers will need to stay one step ahead of the competition with new ingredients, akin to how the market for milk substitutes expanded from soy to embrace soaring demand for nut and oat drinks. Beyond Meat and Nestle’s Sweet Earth use peas for their meatless dishes; Unilever’s The Vegetarian Butcher uses lupine beans to give some meals a fatty, nutty flavor. The possibilities are endless.Yet with innovation comes the risk of alienating consumers and inviting regulation. The magic ingredient at Impossible Foods Inc. – the other big independent plant-based protein maker – is heme, which gives its burgers a bloody meat-like taste. The ingredient is genetically engineered. The U.S. Food and Drug Administration recently found heme to be safe as a color additive, paving the way for sales in supermarkets. But using a genetically-engineered ingredient could turn off the very ethical, health-customers Impossible wants to attract.As big food courts vegans, it will confront pickier consumers than smokers-turned-vapers. Already some are worried about Burger King cooking the Impossible Whopper on the same grill as meat burgers, unless the customer asks for it to be prepared separately.A bigger danger would be if any plant products were found to contain animal traces. Impossible recently partnered with meat processor OSI Group to add more manufacturing capacity and ease supply constraints. It has dedicated capacity at OSI’s facilities, and the production line is not shared with animal-derived products. But it’s a risky move, and one that traditional meat producers going vegan will also have to manage.Like big tobacco, food manufacturers are already confronting challenges to the way they label products. States including Arkansas and Mississippi have banned companies from using the word “burgers” or “dogs” to describe plant-based alternatives. That’s a regulatory breeze compared the crackdown on vaping. In June, San Francisco became the first U.S. city to ban the sale of electronic cigarettes. But it’s still a headwind in what is a nascent industry. While the path of big tobacco highlights some of the challenges facing plant-based protein, there’s one more appetizing similarity. Last year, Altria Group Inc., which owns Philip Morris, took a 35% stake in Juul Labs Inc., the U.S. market-share leader in electronic cigarettes, valuing the company at $38 billion. Beyond Meat is now valued at a staggering $9 billion, almost a third of what food giant Tyson is worth. Such lofty valuations reflect long-term consumer trends. But as the tobacco industry has learned from its foray into alternatives, big food producers shouldn’t assume fake meat is an easy recipe for success. To contact the author of this story: Andrea Felsted at email@example.comTo contact the editor responsible for this story: Stephanie Baker at firstname.lastname@example.orgThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Andrea Felsted is a Bloomberg Opinion columnist covering the consumer and retail industries. She previously worked at the Financial Times.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.
The right mergers and acquisitions (M&A;) can make a good company even better by opening up new markets, expanding capabilities and market share, and diversifying product lines.Not every deal is a guaranteed winner, but investors typically benefit from smart M&A.; A 2016 Booth Business School study found, on average, an increase in overall value for both the acquiring and acquired companies at the time of the merger, and a long-term rise in value for companies that made cash acquisitions.Consider the $81 billion merger between Exxon and Mobil in 1999 that created Exxon Mobil (XOM) - now a $300 billion goliath and the largest publicly traded energy company on U.S. exchanges. Or there's Walt Disney's (DIS) $6 billion buyout of Pixar in 2006. The studio's animated films have generated nearly $11 billion in worldwide box office alone, not accounting for merchandise and other related opportunities.Last year was an especially good year for corporate M&A; thanks to major catalysts provided by tax reform, low borrowing costs and a healthy stock market. Dealmaking hit near-record levels last year. According to Mergermarket, 5,718 transactions closed, and deal volume exceeded $1.5 trillion - the second-highest total ever. Also noteworthy was last year's surge in "mega-deals" - transactions valued at more than $10 billion. These included Keurig Dr. Pepper's (KDP) $27 billion acquisition of soft drink maker Dr. Pepper Snapple Group and pharmacy chain CVS Health's (CVS) $70 billion takeover of health insurance provider Aetna.Here are 15 large-cap stocks that are looking for big things out of their pending or recently closed M&A; deals. These mergers and acquisitions are either already sparking new life in the acquiring companies, or analysts and other market professionals expect them to do so over the coming years. SEE ALSO: The Berkshire Hathaway Portfolio: All 47 Buffett Stocks Explained
Altria Group Inc. said Thursday it will raise its quarterly dividend by 5%, to 84 cents a share from 80 cents. The cigarette and smokeless tobacco products seller said the new dividend will be payable Oct. 10 to shareholders of record on Sept. 16. The stock was up 0.2% in afternoon trading. Based on current stock prices, the new annual dividend rate would imply a dividend yield of 7.25%, compared with yield on the SPDR Consumer Staples Select Sector ETF of 2.64% and the implied yield on the S&P 500 of 2.00%. Altria's current dividend yield is 6.89%. Altria said it has now reached the 50-year dividend increase milestone, as the latest increase marks the 54th time it has raised its dividend over the past half century. The stock has lost 22% over the past year, while the consumer staples ETF has has climbed 11.6% and the S&P 500 has gained 2.2%.
When it comes to Canadian cannabis companies, Hexo (NYSE:HEXO) doesn't always get the recognition it deserves. Hexo stock is often seen as the little brother to bigger players like Aurora Cannabis (NYSE:ACB) and Canopy Growth (NYSE:CGC). Source: Shutterstock InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut if you're looking to get in at the ground floor with a growing cannabis company, HEXO isn't a bad option. The company's sales have grown by massive amounts over the last 12 months. And the company predicted its revenue will double over the next quarter. Of course, many investors are hesitant given some of the recent uncertainty in the Canadian cannabis industry. Here are three things you need to know before investing in Hexo stock. The Cannabis Industry Is On Unsteady FootingThere's been a lot of volatility in the cannabis industry recently. First, there was the revelation that CannTrust (NYSE:CTST) was illegally growing marijuana in unlicensed rooms. And most recently, Canopy Growth released an abysmal earnings report showing that the company isn't as profitable as many investors believed. All of this has caused marijuana stocks across the board to fall.The cannabis industry is going to be huge, but it's still unclear which companies will be around to cash in on it. At this point, it's impossible to predict which company will fall victim to regulatory issues or plunging sales next. Hexo Stock Isn't Yet ProfitableHexo's most recent earnings report showed that the company achieved huge growth over the past year. In the third quarter of 2018, the company's sales were a mere CAD $1.24 million. This year, that figure came in at CAD $15.9 million.However, like many cannabis companies, Hexo is not yet profitable. The company may have earned more during the third quarter, but it also spent a lot more money. Its total operating expenses came to CAD $24.1 million during the third quarter.And the company is still held back by its production capacity. However, the company did open a 1-million-square-foot greenhouse in April so it will be interesting to see how that impacts the company during its Q4. HEXO Has Long-Term PotentialLooking forward, Hexo stock does have a lot of long-term potential. The company's sales are impressive and it currently holds a 30% market share in Quebec.And Hexo is actively working to improve its production capacity. In March, the company announced it planned to acquire the Toronto-based Newstrike Brands. Once these facilities are fully operational this will give Hexo an additional 470,000 square feet in production space. The company currently makes most of its revenue from recreational and medicinal marijuana sales. But its recent partnership with Molson Coors (NYSE:TAP) sets the stage for Hexo to lead the market in cannabis-infused beverages, once legalized. * 10 Marijuana Stocks That Could See 100% Gains, If Not More My advice with Hexo is to proceed with caution. The fundamentals look promising but there are just too many unknowns going forward. As of this writing, Jamie Johnson did not hold a position in any of the aforementioned stocks. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Marijuana Stocks That Could See 100% Gains, If Not More * 11 Stocks Under $10 to Buy Now * 6 China Stocks to Buy on the Dip The post Will Hexo Stock Be Around for the Long Haul? appeared first on InvestorPlace.
The hard seltzer alcohol market has exploded over the last year and could expand to a $2.5 billion market by 2021 and Constellation Brands, Inc. (NYSE: STZ ) could see part of its beer portfolio negatively ...
Canopy Growth (NYSE:CGC) stock has taken a pounding. Shares are down nearly 25% in the past month, from $35.40 per share to $26.57 per share. The investor exodus from marijuana stocks has been brutal.Source: Shutterstock With excess supply outgunning demand, it's no wonder the bull case for pot stocks is tough to justify. But can investors expect a rebound in Canopy Growth stock? Let's take a closer look at the future of CGC shares. Recent Performance of CGC StockCGC released earnings on Aug. 14. For the quarter ending June 30, net revenue was C$90.5 million, down from C$94.1 million in the prior quarter. Overestimating demand for CBD oils and capsules, Canopy lost out while its peers such as Aurora Cannabis (NYSE:ACB) continued to grow revenue. As a result, CGC saw operating losses of C$123.1 million for the quarter.InvestorPlace - Stock Market News, Stock Advice & Trading TipsDespite oversupply in the market, CGC and the other Canadian cannabis names continue to ramp up production. Canopy harvested about 41,000 kg during the quarter. But sales were only 10,549 kg or kg equivalents. Like Aurora Cannabis, Canopy has gotten ahead of itself in its fast drive to scale operations.But is short-term thinking not the way to go with cannabis stocks? As InvestorPlace contributor Luke Lango wrote on Aug. 19, "there is still visibility for Canopy to one day be a $50 to 100 billion company." Investors buying in now may see tremendous gains over a long time frame. * 10 Marijuana Stocks That Could See 100% Gains, If Not More What about investors with a shorter time horizon? Is upside priced in, or can investors get a discount? Let's take a look at the valuation of Canopy Growth stock. Valuation: Canopy Growth Stock Still FrothyCanopy Growth stock currently trades at a Enterprise Value/Sales (EV/Sales) ratio of 32.2. This is a discount to the current EV/Sales valuation of Aurora Cannabis. ACB trades at an EV/Sales ratio of 48.2 In terms of other peers in the "cannabisphere," Cronos Group (NASDAQ:CRON) continues to trade at a high valuation (EV/Sales of 150.7). Tilray (NASDAQ:TLRY) trades at a discount to CGC, with an EV/Sales ratio of 31.4.With the recent beat-down of Canopy Growth stock, shares are now a bargain compared to Aurora Cannabis. But, as I wrote earlier this month, Aurora Cannabis seems to have a better growth playbook. By focusing on the medical marijuana space, Aurora is the safer cannabis stock play. But an overlooked risk factor in both cannabis stocks is dilution. The use of share issuance and warrants to finance unprofitable operations minimizes upside for investors. CGC Stock Dilution Risks ContinueThe company's partnership with Constellation Brands (NYSE:STZ) was initially seen as a boost for CGC stock. But as the partnership progresses, it is clear the deal is terrible for shareholders. Constellation's $5 billion dollar investment included the issuance of warrants. These warrants came with certain covenants to protect Constellation from dilution. CGC's proposed buyout of Acreage Holdings (OTCMKTS:ACRGF) triggered a renegotiation of warrants. Due to this revision, CGC was forced to reprice the Tranche B warrants, resulting in a C$1.2 billion non-cash charge.As I wrote on July 29, dilution continues to be a problem for Canopy Growth stock. This dilution risks goes beyond the Constellation partnership. $600 million in convertible debt comes due in 2023. The conversion price is set at $48.18 a share. If CGC stock continues to languish under this strike price, the company will likely need to raise more capital once the notes mature.Of course, Canopy Growth could be profitable by 2023, and would have an easier time refinancing the debt. But investors should take the dilution risk seriously. With much of Canopy's potential priced into shares, dilutive capital raises could cap the stock's upside potential. Bottom Line: The Canopy Sell-Off Isn't OverCanopy stock is down more than 50% from its 52-week high. But shares could go lower. With Canadian market growth nonexistent, Canopy needs U.S. legalization fast in order to move the needle. With federal legalization still years off, CGC will likely continue to burn cash as it scales up operations. The partnership with Constellation Brands provides plenty of capital to keep the lights on. But the terms of the partnership give Constellation an easy way to takeover the company at a discount.So what's the call on CGC stock? Investors should continue to wait on the sidelines until the situation improves. If Canopy Growth stock falls another 50% (or more), there could be a buying opportunity. I do not deny that we are the early stages of the marijuana legalization story. But investors need to wait until hype has dissipated to consider stocks such as CGC.As of this writing, Thomas Niel did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Marijuana Stocks That Could See 100% Gains, If Not More * 11 Stocks Under $10 to Buy Now * 6 China Stocks to Buy on the Dip The post Down 25% in a Month, CGC Stock Could Fall Further appeared first on InvestorPlace.
India's health ministry has proposed a ban on the production and import of electronic cigarettes, documents seen by Reuters showed, potentially jeopardizing the expansion plans of big firms like Juul Labs and Philip Morris International. The ministry has proposed that the government issue an executive order banning the devices in the public interest, saying it was needed to ensure e-cigarettes don't become an "epidemic" among children and young adults. Health officials are proposing jail terms of up to three years, with a penalty of up to 500,000 rupees ($7,000), for repeat offenders against the new rules, according to a draft of the executive order.
Boston Beer (SAM) remains committed to the three-point growth plan. Also, the company's focus on cost savings, long-term innovation, and the revival of Samuel Adams and Angry Orchard brands bode well.
Japan's second-largest city, Yokohama, said on Thursday it would bid to host a casino resort, a newly legalised industry the government hopes will stimulate the economy and tourism. Yokohama, facing Tokyo Bay and located a short train ride from the capital, joins candidates such as Osaka, Nagasaki and Wakayama vying to host integrated resorts (IR) expected to attract more tourists and investment. Las Vegas Sands Corp promptly announced interest in Yokohama, saying it would pursue IR development there or in the capital rather than in Osaka.
It took them a little while to believe it. But, after assessing what the minutes from the most recent Federal Reserve governors meeting said, investors decided the glass was half full. The S&P 500 ended Wednesday's action at 2924.43, up 0.82%, and in the middle of several moving average lines.Source: Shutterstock Target (NYSE:TGT), incredibly enough, led the charge, rallying more than 20% on the heels of an impressive second-quarter report. Same-store sales grew 3.4%, and e-commerce revenue was up 34%. That's a tremendous win for the retailer, which got a slow start on the digital sales front.Nordstrom (NYSE:JWN) knocked it out of the park too, rallying more than 5% in front of its post-close report, then adding more than 10% in response to its solid quarterly earnings figure. Although sales came up short of expectations, income of 90 cents per share easily topped expectations of only 77 cents.InvestorPlace - Stock Market News, Stock Advice & Trading TipsNot every name was a winner, though. Holding the market back more than most others was Cree (NASDAQ:CREE), and its 16% stumble. Although the chipmaker topped last quarter's sales and profit expectations, investors were horrified of its guidance for the quarter now underway.As Thursday's action gets going, however, it's the stock charts of News Corp (NASDAQ:NWSA), Bank of America (NYSE:BAC) and Philip Morris International (NYSE:PM) that are of the most interest. Philip Morris International (PM)A year ago, Philip Morris International was in real trouble. PM stock was not only trending lower, it plunged April and wasn't acting as if there was any interest in a recovery. Even once the bulls started to test the waters by October, they had the rug pulled out from underneath them. In one fell swoop in December, Philip Morris was deep into new 52-week territory. * 10 Marijuana Stocks That Could See 100% Gains, If Not More Things do seem to have taken a turn for the better in the meantime though. While it has been anything but a straight-line effort, the choppiness has also been net bullish. One more good 'umph' could push PM shares over the hump. Click to Enlarge• It started in March, but that effort buckled until it was renewed in July. That's when Philip Morris broke back above the falling resistance line plotted in red on the weekly chart.• It doesn't look like it on the daily chart, but it's there. All the moving average lines, and the stock itself, are converging to a point that could be setting up an explosive divergence.• Although the undertow is bullish, there's still a significant ceiling ahead. As marked on the weekly chart, in blue, the $92.86 level has capped a couple of rally efforts since late last year. News Corp (NWSA)A week and a half ago, News Corp shares jumped higher, pivoting out of a lull at a point exactly where support would be expected to be found. The move rekindled a big gain in June that shook shares out of a rut and possibly back into an uptrend.That move persisted for a couple more days, albeit at a slower pace, until finally a familiar technical ceiling stopped the effort cold. The subsequent pullback was quelled as well though, with the advance rekindled last week. Although the ceiling remains in place, the odds of punching through this effort improve every day. Click to Enlarge• The technical ceiling is around $14.40, plotted with a yellow line on both stock charts, where shares peaked in November and again earlier this month.• The daily chart of News Corp also makes clear that the white 200-day moving average line and now the blue 20-day moving average line are serving as support, ending selloffs.• As of yesterday, the gray 100-day moving average has moved above the 200-day line, and all four key moving average lines are sloped upward. The underlying momentum is undeniably bullish. Bank of America (BAC)Banks like Bank of America aren't in absolute dire straits, despite the recent rate cut. Though lower rates mean weaker profit margins on lending activity, the economy is reasonably healthy. Banks, including B of A, will be fine.That doesn't mean BAC stock is going to hold up against a near-term bear attack though. A well-established but sinking floor was met again last week, and though traders pushed up and off of it a little bit, it's still within reach of a break below that floor. And, the backdrop is less than encouraging. Click to Enlarge• The support in focus is marked with a red dashed line on both stock charts. It connects most of the major lows since the middle of last year, and is clearly moving lower.• It has been messy on this front since the beginning of the year, we're on the cusp of seeing shorter-term moving average lines slide below longer-term moving averages.• It's only evident on the weekly chart, but it's crystal clear there … there's growing volume behind the recent weakness. The Chaikin line has fallen below the zero level as of last week.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about him at his website jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Marijuana Stocks That Could See 100% Gains, If Not More * 11 Stocks Under $10 to Buy Now * 6 China Stocks to Buy on the Dip The post 3 Big Stock Charts for Thursday: Bank of America, News Corp and Philip Morris appeared first on InvestorPlace.
Dividend paying stocks like Las Vegas Sands Corp. (NYSE:LVS) tend to be popular with investors, and for good reason...
Japan's second-largest city, Yokohama, said on Thursday it would bid to host a casino resort, a newly legalised industry the government hopes will stimulate the economy and tourism. Yokohama, facing Tokyo Bay and located a short train ride from the capital, joins candidates such as Osaka, Nagasaki and Wakayama vying to host integrated resorts (IR) expected to attract more tourists and investment.
Yokohama, Japan's second-largest city, raised its hand on Thursday to host a casino resort, a newly legalised industry the government hopes will stimulate the economy and tourism. Yokohama Mayor Fumiko Hayashi said the city was preparing a bid, with expectations for such a resort to bring the city a "virtuous cycle" of greater economic investment and growth. Yokohama, facing Tokyo Bay and located a short train ride from the capital, joins other candidates such as Osaka, Nagasaki and Wakayama vying to host integrated resorts (IR) expected to attract more tourists and investment.
Altria (MO) stock has lagged the broader market in 2019. On August 17, the CDC noted that it is investigating lung diseases linked to e-cigarette use.